These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23455568)

  • 1. The evolutionary consequences of alternative types of imperfect vaccines.
    Magori K; Park AW
    J Math Biol; 2014 Mar; 68(4):969-87. PubMed ID: 23455568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of equine influenza virus in vaccinated horses.
    Murcia PR; Baillie GJ; Stack JC; Jervis C; Elton D; Mumford JA; Daly J; Kellam P; Grenfell BT; Holmes EC; Wood JL
    J Virol; 2013 Apr; 87(8):4768-71. PubMed ID: 23388708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a blocking ELISA for antibodies to equine influenza virus as a test to distinguish between naturally infected and vaccinated horses: proof of concept studies.
    Kirkland PD; Delbridge G
    Aust Vet J; 2011 Jul; 89 Suppl 1():45-6. PubMed ID: 21711288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
    Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus.
    Paillot R; Kydd JH; Sindle T; Hannant D; Edlund Toulemonde C; Audonnet JC; Minke JM; Daly JM
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):225-33. PubMed ID: 16621023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8).
    Newton JR; Townsend HG; Wood JL; Sinclair R; Hannant D; Mumford JA
    Equine Vet J; 2000 Jan; 32(1):65-74. PubMed ID: 10661388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the response to an accelerated immunisation schedule using a canarypox-vectored equine influenza vaccine, shortened interdose intervals and vaccination of young foals.
    Minke JM; El-Hage CM; Tazawa P; Homer D; Lemaitre L; Cozette V; Gilkerson JR; Kirkland PD
    Aust Vet J; 2011 Jul; 89 Suppl 1():137-9. PubMed ID: 21711312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.
    Minke JM; Toulemonde CE; Coupier H; Guigal PM; Dinic S; Sindle T; Jessett D; Black L; Bublot M; Pardo MC; Audonnet JC
    Am J Vet Res; 2007 Feb; 68(2):213-9. PubMed ID: 17269889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination program in the response to the 2007 equine influenza outbreak in Australia.
    Perkins NR; Webster WR; Wright T; Denney I; Links I
    Aust Vet J; 2011 Jul; 89 Suppl 1():126-34. PubMed ID: 21711310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine.
    Lopez AM; Hecker R; Mutwiri G; van Drunen Littel-van den Hurk S; Babiuk LA; Townsend HG
    Vet Immunol Immunopathol; 2006 Nov; 114(1-2):103-10. PubMed ID: 16950519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses.
    Chambers TM; Quinlivan M; Sturgill T; Cullinane A; Horohov DW; Zamarin D; Arkins S; García-Sastre A; Palese P
    Equine Vet J; 2009 Jan; 41(1):87-92. PubMed ID: 19301588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination against equine influenza: quid novi?
    Paillot R; Hannant D; Kydd JH; Daly JM
    Vaccine; 2006 May; 24(19):4047-61. PubMed ID: 16545507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
    Paillot R; Grimmett H; Elton D; Daly JM
    Vet Res; 2008; 39(3):21. PubMed ID: 18252187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole inactivated equine influenza vaccine: Efficacy against a representative clade 2 equine influenza virus, IFNgamma synthesis and duration of humoral immunity.
    Paillot R; Prowse L; Montesso F; Huang CM; Barnes H; Escala J
    Vet Microbiol; 2013 Mar; 162(2-4):396-407. PubMed ID: 23146168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a novel equine influenza virus live-attenuated vaccine.
    Rodriguez L; Reedy S; Nogales A; Murcia PR; Chambers TM; Martinez-Sobrido L
    Virology; 2018 Mar; 516():76-85. PubMed ID: 29331866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding.
    Paillot R; Prowse L; Donald C; Medcalf E; Montesso F; Bryant N; Watson J; Jeggo M; Elton D; Newton R; Trail P; Barnes H
    Vet Immunol Immunopathol; 2010 Aug; 136(3-4):272-83. PubMed ID: 20400185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Authors do not believe article provides evidence of vaccine efficacy.
    Morley PS; Townsend HG; Haines DM
    Am J Vet Res; 2001 May; 62(5):648. PubMed ID: 11341378
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
    Heldens JG; Pouwels HG; van Loon AA
    Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective priming of foals born to immune dams against influenza by a canarypox-vectored recombinant influenza H3N8 vaccine.
    Minke JM; Toulemonde CE; Dinic S; Cozette V; Cullinane A; Audonnet JC
    J Comp Pathol; 2007 Jul; 137 Suppl 1():S76-80. PubMed ID: 17559865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of immunity induced by an equine influenza and tetanus combination vaccine formulation adjuvanted with ISCOM-Matrix.
    Heldens JG; Pouwels HG; Derks CG; Van de Zande SM; Hoeijmakers MJ
    Vaccine; 2010 Oct; 28(43):6989-96. PubMed ID: 20728523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.